<DOC>
	<DOCNO>NCT01153360</DOCNO>
	<brief_summary>This study plan medicate oral T3 ( Liothyronine ) patient plan OPCAB ( off- pump coronary bypass graft surgery . The aim study assess effect oral triiodothyronine ( T3 ) therapy postoperative thyroid hormone concentration , hemodynamic variable outcomes patient undergo OPCAB randomize , control trial .</brief_summary>
	<brief_title>Peri-operative Oral Triiodothyronine Replacement Therapy Decrease Risk Transient Atrial Fibrillation After Off-pump Coronary Artery Bypass Surgery</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Euthyroid Sick Syndromes</mesh_term>
	<criteria>Patients undergo Offpump coronary artery bypass graft No normal sinus rhythm , History thyroid disease Abnormal thyroid hormone Renal dysfunction Hepatic dysfunction LVEF &lt; 30 % Recent MI Active infection 1~15</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>